12 Emerging Companies to Watch in Neurotech Space
Brain-computer interface (BCI) technologies are rapidly becoming the spotlight of the neurotech industry, with Neuralink at the forefront. Recently, Neuralink …
Biopharma Insights
The Pivotal Role of AI in Clinical Trials: From Digital Twins to Synthetic Control Arms
Artificial Intelligence (AI) is redefining the clinical trial process, offering solutions that address long-standing challenges in drug development. The traditional …
5 AI-Powered Companies Transforming the Future of Fertility Care
The field of fertility treatments is experiencing a surge in demand, fueled by several significant factors. A shift towards starting …
17 Companies Pioneering AI Foundation Models in Pharma and Biotech
Foundation models represent a relatively new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. Foundation …
Why AI Needs to Be at the Center of mRNA Design
One of the biggest hurdles in mRNA development is the in vitro to in vivo gap; results that look strong …
Phesi Reports GLP-1 Trials Now Span 100+ Diseases
Phesi has published an analysis showing that GLP-1 drugs are now being tested across more than 100 diseases, extending well …
Digital Twins in Rare Diseases: From Virtual Trials to Personalized Care
Digital twins are moving from aerospace, automotive, and manufacturing into medicine and drug development, with the potential to transform how …
How AI Is Transforming Medicinal Chemistry Between Discovery and Manufacture
In medicinal chemistry, the “make” stage of the design–make–test–analyze (DMTA) cycle is often where good ideas go to die. Synthetic …
"AI Scientists" - New Collaborators for Rare Disease Research?
In the quest to understand and treat the over 6,000 rare diseases, researchers encounter a number of limitations – in …
What are Foundation Models in Biology and Healthcare?
Content: History of AI in the Context of Foundation Models The Technology Stack Behind Foundation Models The Paradigm Shift in …
Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome
With DeepMind’s release of AlphaGenome—a deep learning model that can predict the relevance of variants in both coding and non-coding …
Beyond Legacy Tools: Defining Modern AI Drug Discovery for 2025 and Beyond
In this report: Intro: The New Framework “AI Drug Discovery” is About Holism "AI Drug Discovery" is About Building Software …